OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 60 filers reported holding OBALON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $374,000 | -48.1% | 108,998 | 0.0% | 0.04% | -53.7% |
| Q4 2017 | $720,000 | -30.7% | 108,998 | 0.0% | 0.10% | -41.7% |
| Q3 2017 | $1,039,000 | -3.8% | 108,998 | 0.0% | 0.16% | -12.4% |
| Q2 2017 | $1,080,000 | -7.3% | 108,998 | 0.0% | 0.19% | -23.5% |
| Q1 2017 | $1,165,000 | +75.5% | 108,998 | +45.3% | 0.24% | +57.8% |
| Q4 2016 | $664,000 | – | 74,998 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|